Tevogen Bio Holdings (TVGN) Return on Capital Employed (2023 - 2026)

Tevogen Bio Holdings has reported Return on Capital Employed for 4 years, with the latest figure at 809.66% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 11498.0% year-over-year to 809.66%; the trailing twelve-month figure through Mar 2026 stood at 809.66% (up 11498.0% YoY), and the FY2025 full-year result was 830.87%, down 34402.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 809.66%, down from 993.88% in the prior quarter.
• The five-year high for Return on Capital Employed was 1311.32% in Q3 2025, with the low at 12.72% in Q4 2023.
• Historically, Return on Capital Employed has averaged 774.0% across 4 years, with a median of 799.58% in 2025.
• Annual changes were most pronounced in 2024 — Return on Capital Employed soared 102392 bps — and 2025, when it plunged 10542 bps.
• Tevogen Bio Holdings' Return on Capital Employed stood at 12.72% in 2023, then surged by 8050 bps to 1036.64% in 2024, then dropped by 4 bps to 993.88% in 2025, then dropped by 19 bps to 809.66% in 2026.
• The last three Return on Capital Employed figures came in at 809.66% (Q1 2026), 993.88% (Q4 2025), and 1311.32% (Q3 2025), per Business Quant data.